BR112017027332A2 - topical compositions comprising a corticosteroid and a retinoid for treating psoriasis. - Google Patents
topical compositions comprising a corticosteroid and a retinoid for treating psoriasis.Info
- Publication number
- BR112017027332A2 BR112017027332A2 BR112017027332-2A BR112017027332A BR112017027332A2 BR 112017027332 A2 BR112017027332 A2 BR 112017027332A2 BR 112017027332 A BR112017027332 A BR 112017027332A BR 112017027332 A2 BR112017027332 A2 BR 112017027332A2
- Authority
- BR
- Brazil
- Prior art keywords
- retinoid
- corticosteroid
- topical compositions
- treating psoriasis
- psoriasis
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title 1
- 239000003246 corticosteroid Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000004492 retinoid derivatives Chemical class 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562181481P | 2015-06-18 | 2015-06-18 | |
| US62/181,481 | 2015-06-18 | ||
| PCT/US2016/035991 WO2016205001A1 (en) | 2015-06-18 | 2016-06-06 | Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112017027332A2 true BR112017027332A2 (en) | 2018-09-04 |
| BR112017027332B1 BR112017027332B1 (en) | 2023-11-07 |
Family
ID=56131662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017027332-2A BR112017027332B1 (en) | 2015-06-18 | 2016-06-06 | Topical pharmaceutical composition to treat psoriasis and its use |
Country Status (20)
| Country | Link |
|---|---|
| US (7) | US10251895B2 (en) |
| EP (1) | EP3310389B1 (en) |
| JP (1) | JP6997624B2 (en) |
| KR (2) | KR20240035898A (en) |
| CN (1) | CN108282998B (en) |
| AU (1) | AU2016279801B2 (en) |
| BR (1) | BR112017027332B1 (en) |
| CA (1) | CA2988577A1 (en) |
| CY (1) | CY1123354T1 (en) |
| DK (1) | DK3310389T3 (en) |
| ES (1) | ES2812451T3 (en) |
| HR (1) | HRP20201250T1 (en) |
| HU (1) | HUE050603T2 (en) |
| LT (1) | LT3310389T (en) |
| MX (1) | MX2017015990A (en) |
| PL (1) | PL3310389T3 (en) |
| PT (1) | PT3310389T (en) |
| RS (1) | RS60672B1 (en) |
| SI (1) | SI3310389T1 (en) |
| WO (1) | WO2016205001A1 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11957753B2 (en) | 2010-11-22 | 2024-04-16 | Bausch Health Ireland Limited | Pharmaceutical formulations containing corticosteroids for topical administration |
| AU2016279801B2 (en) | 2015-06-18 | 2021-09-09 | Valeant Pharmaceuticals North America | Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis |
| RU2699027C2 (en) * | 2015-07-13 | 2019-09-03 | Др. Редди'С Лабораториз Лтд. | Retinoid compositions for topical application |
| US11311482B2 (en) | 2017-05-12 | 2022-04-26 | Bausch Health Us, Llc | Topical compositions and methods for treating skin diseases |
| CA3063371A1 (en) * | 2017-05-12 | 2018-11-15 | Bausch Health Us, Llc | Topical compositions and methods for treating skin diseases |
| CA3067657A1 (en) * | 2017-06-23 | 2018-12-27 | Laboratorios Salvat, S.A. | An oil-in-water nanoemulsion composition of clobetasol |
| US10653656B2 (en) | 2018-04-05 | 2020-05-19 | Bausch Health Ireland Limited | Topical pharmaceutical compositions for treating skin conditions |
| WO2019195802A1 (en) * | 2018-04-05 | 2019-10-10 | Bausch Health Ireland Limited | Polymeric emulsion delivery systems |
| US10945952B2 (en) | 2019-03-14 | 2021-03-16 | Crescita Therapeutics Inc. | Rinse-off compositions and uses thereof for delivery of active agents |
| KR102327827B1 (en) | 2019-11-01 | 2021-11-18 | 한국과학기술연구원 | Composition for improving psoriasis symptom comprising extract of Curcuma longa L and UV treatment |
| KR102451304B1 (en) | 2020-09-14 | 2022-10-07 | 한국과학기술연구원 | Composition for improving psoriasis symptom comprising extract of Thalictrum squarrosum steph |
| KR102527907B1 (en) | 2020-09-14 | 2023-05-03 | 한국과학기술연구원 | Composition for improving psoriasis symptom comprising extract of Sphallerocaprus gracilis |
| KR102461001B1 (en) | 2020-09-14 | 2022-11-01 | 한국과학기술연구원 | Composition for improving psoriasis symptom comprising extract of Dianthus superbus L. |
| KR20230041257A (en) | 2021-09-17 | 2023-03-24 | 한국과학기술연구원 | Composition for improving psoriasis symptom comprising cimicifugolide A |
| KR20230041255A (en) | 2021-09-17 | 2023-03-24 | 한국과학기술연구원 | Composition for improving psoriasis symptom comprising extract of Aruncus dioicus var. kamtschaticus |
| CN113975249B (en) * | 2021-10-14 | 2023-01-03 | 中山大学·深圳 | Preparation of Tris-BNP nano-particles and application thereof in treatment of skin diseases |
| CN113712918A (en) * | 2021-10-28 | 2021-11-30 | 济南纽华医药科技有限公司 | Apremilast microemulsion and preparation method thereof |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU75903A1 (en) | 1976-09-29 | 1978-05-16 | ||
| NL7105591A (en) | 1971-04-24 | 1972-10-26 | Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4- | |
| DE2655570A1 (en) | 1975-12-12 | 1977-06-16 | Ciba Geigy Ag | NEW POLYHALOGSTEROIDS AND METHODS FOR THEIR PRODUCTION |
| US4048310A (en) | 1976-02-24 | 1977-09-13 | E. R. Squibb & Sons, Inc. | Topical steroid formulation in form of lotion or cream |
| US4083974A (en) | 1977-03-07 | 1978-04-11 | The Upjohn Company | Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether |
| JPS5850964B2 (en) | 1978-03-07 | 1983-11-14 | 東興薬品工業株式会社 | Steroid-containing cream preparation and its manufacturing method |
| US4233295A (en) | 1979-05-31 | 1980-11-11 | E. R. Squibb & Sons, Inc. | Corticosteroid formulations containing sebacate carrier |
| US4299828A (en) | 1979-05-31 | 1981-11-10 | E. R. Squibb & Sons, Inc. | Corticosteroid stick formulations |
| AU5794680A (en) | 1979-05-31 | 1980-12-04 | E.R. Squibb & Sons, Inc. | Corticosteroid stick formulations |
| CH649923A5 (en) | 1980-10-06 | 1985-06-28 | Glaxo Group Ltd | TOPICALLY AVAILABLE PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-INFLAMMATORY STEROIDS. |
| JPS58225009A (en) | 1982-06-23 | 1983-12-27 | Shionogi & Co Ltd | Pharmaceutical preparation of corticosteroid for external use |
| DE3225848A1 (en) | 1982-07-07 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | PREPARATION OF CORTICOIDS FOR TOPICAL APPLICATION |
| GB8401965D0 (en) | 1984-01-25 | 1984-02-29 | Beecham Group Plc | Composition |
| CA1303991C (en) | 1986-03-31 | 1992-06-23 | Chung H. Cheng | Composition and method for delivering a steroid active ingredient |
| US5019569A (en) | 1986-11-03 | 1991-05-28 | Ortho Pharmaceutical Corporation | Reversal of glucocorticoid-induced skin atrophy |
| JPH0676328B2 (en) | 1987-04-14 | 1994-09-28 | 株式会社大塚製薬工場 | Steroid cream formulation |
| JPH0676327B2 (en) | 1987-04-14 | 1994-09-28 | 株式会社大塚製薬工場 | Steroid ointment formulation |
| JPH07116026B2 (en) | 1987-07-07 | 1995-12-13 | 株式会社資生堂 | External emulsion containing diclofenac sodium |
| AU6974191A (en) | 1989-12-20 | 1991-07-18 | Schering Corporation | Stable cream and lotion bases for lipophilic drug compositions |
| KR0168436B1 (en) | 1990-03-02 | 1999-01-15 | 후쿠하라 요시하루 | Oil-in- water type emulsified composition comprising non-steroidal antiphlogistic and analgesic drug |
| US5326566A (en) | 1991-05-17 | 1994-07-05 | Bristol-Myers Squibb Company | Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
| TW218849B (en) * | 1991-05-17 | 1994-01-11 | Bristol Myers Squibb Co | |
| CA2282682C (en) | 1997-02-20 | 2008-08-19 | Allergan Sales, Inc. | Tazarotene and corticosteroid treatment for psoriasis |
| SE9800729L (en) | 1998-03-06 | 1999-09-07 | Scotia Lipidteknik Ab | New topical formulation I |
| GB9823036D0 (en) | 1998-10-22 | 1998-12-16 | Glaxo Group Ltd | Fluticasone lotion having improved vasoconstrictor activity |
| AU2877800A (en) * | 1999-02-12 | 2000-08-29 | Susan Bershad | Short contact treatment of psoriasis with topical retinoids |
| US6730308B1 (en) * | 1999-03-08 | 2004-05-04 | Allergan, Inc. | Tazarotene and alpha hydroxy acid treatment for psoriasis and/or photodamage |
| US6479058B1 (en) | 1999-09-02 | 2002-11-12 | Mccadden Michael E. | Composition for the topical treatment of poison ivy and other forms of contact dermatitis |
| US6656928B1 (en) | 1999-09-02 | 2003-12-02 | Mccadden Michael E. | Composition for the topical treatment of rashes, dermatoses and lesions |
| US6387383B1 (en) | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| DK1331927T3 (en) * | 2000-10-27 | 2008-05-05 | Leo Pharma As | Topical composition containing at least one vitamin D or vitamin D analogue and at least one dietary chosteroid |
| US6709663B2 (en) | 2001-08-31 | 2004-03-23 | Healthpoint, Ltd. | Multivesicular emulsion drug delivery systems |
| US6765001B2 (en) | 2001-12-21 | 2004-07-20 | Medicis Pharmaceutical Corporation | Compositions and methods for enhancing corticosteroid delivery |
| US7544674B2 (en) | 2002-10-25 | 2009-06-09 | Galderma S.A. | Topical skin care composition |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US7820145B2 (en) | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| CN1210034C (en) * | 2002-12-06 | 2005-07-13 | 重庆华邦制药股份有限公司 | Medicinal composition for treating psoriasis |
| WO2004058262A1 (en) | 2002-12-31 | 2004-07-15 | Wockhardt Limited | Benzoquinolizine-2-carboxylic acid-containing compositions |
| JP2004359585A (en) | 2003-06-03 | 2004-12-24 | Medorekkusu:Kk | Coating film-forming type external preparation containing adrenocorticosteroid medicine |
| CN1210035C (en) * | 2003-09-29 | 2005-07-13 | 中国医学科学院皮肤病研究所 | Complex external medicine for treating psoriasis |
| CN1210041C (en) * | 2003-09-29 | 2005-07-13 | 中国医学科学院皮肤病研究所 | Complex external medicine for treating acne |
| US8741333B2 (en) | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
| JPWO2006098353A1 (en) | 2005-03-15 | 2008-08-28 | 協和醗酵工業株式会社 | Topical preparation |
| TW200740441A (en) * | 2005-06-17 | 2007-11-01 | Combinatorx Inc | Methods and reagents for the treatment of inflammatory disorders |
| WO2007100376A2 (en) | 2005-12-14 | 2007-09-07 | Zars, Inc. | Compositions and methods for dermal delivery of drugs |
| PL2494959T3 (en) | 2006-07-05 | 2015-06-30 | Foamix Pharmaceuticals Ltd | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| EP2097065A2 (en) | 2006-11-29 | 2009-09-09 | Foamix Ltd. | Foamable waterless compositions with modulating agents |
| MX2010002592A (en) | 2007-09-10 | 2010-03-30 | Glenmark Pharmaceuticals Ltd | Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid. |
| WO2009084020A2 (en) | 2007-10-18 | 2009-07-09 | Glenmark Pharmaceuticals Limited | Topical composition comprising halobetasol and salicylic acid |
| CN105147608B (en) | 2008-06-26 | 2019-12-10 | 安特里奥公司 | Dermal delivery |
| US10568859B2 (en) * | 2009-02-25 | 2020-02-25 | Mayne Pharma Llc | Topical foam composition |
| US20130310355A1 (en) | 2009-12-15 | 2013-11-21 | Young Pharmaceuticals, Inc. | Low toxicity topical active agent delivery system |
| WO2012051614A2 (en) | 2010-10-15 | 2012-04-19 | Kulesza John E | Delivery of hydrophobic bioactive agents |
| EP2635276B1 (en) * | 2010-11-04 | 2017-07-19 | 442 Ventures, LLC | Composition and its use in method for treating skin conditions |
| US8809307B2 (en) | 2010-11-22 | 2014-08-19 | Dow Pharmaceutical Sciences, Inc. | Pharmaceutical formulations containing corticosteroids for topical administration |
| US9034926B2 (en) * | 2010-12-30 | 2015-05-19 | Nicholas V. Perricone | Topical nitrone spin trap compositions for psoriasis |
| EP2714016A1 (en) | 2011-06-03 | 2014-04-09 | Allergan, Inc. | Targeted delivery of retinoid compounds to the sebaceous glands |
| JP2015503573A (en) * | 2012-01-09 | 2015-02-02 | アルミラル・ソシエダッド・アノニマＡｌｍｉｒａｌｌ， Ｓ．Ａ． | Topical pharmaceutical composition comprising bexarotene and corticosteroid |
| US20140112959A1 (en) | 2012-10-18 | 2014-04-24 | MiCal Pharmaceuticals LLC - H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limite | Topical steroid composition and method |
| CN104288157B (en) * | 2013-01-29 | 2018-04-13 | 江苏知原药业有限公司 | Solid dispersions comprising clobetasol propionate and Tretinoin and preparation method thereof |
| WO2015044857A1 (en) * | 2013-09-25 | 2015-04-02 | Ranbaxy Laboratories Limited | Topical spray composition of halobetasol |
| AU2016279801B2 (en) | 2015-06-18 | 2021-09-09 | Valeant Pharmaceuticals North America | Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis |
| US20190133943A1 (en) | 2015-06-18 | 2019-05-09 | Valeant Pharmaceuticals North America | Topical compositions and methods for treating skin diseases |
| CA3063371A1 (en) | 2017-05-12 | 2018-11-15 | Bausch Health Us, Llc | Topical compositions and methods for treating skin diseases |
| US11311482B2 (en) * | 2017-05-12 | 2022-04-26 | Bausch Health Us, Llc | Topical compositions and methods for treating skin diseases |
-
2016
- 2016-06-06 AU AU2016279801A patent/AU2016279801B2/en active Active
- 2016-06-06 ES ES16729470T patent/ES2812451T3/en active Active
- 2016-06-06 PL PL16729470T patent/PL3310389T3/en unknown
- 2016-06-06 CA CA2988577A patent/CA2988577A1/en active Pending
- 2016-06-06 LT LTEP16729470.1T patent/LT3310389T/en unknown
- 2016-06-06 HU HUE16729470A patent/HUE050603T2/en unknown
- 2016-06-06 MX MX2017015990A patent/MX2017015990A/en active IP Right Grant
- 2016-06-06 BR BR112017027332-2A patent/BR112017027332B1/en active IP Right Grant
- 2016-06-06 KR KR1020247006984A patent/KR20240035898A/en active Search and Examination
- 2016-06-06 WO PCT/US2016/035991 patent/WO2016205001A1/en active Application Filing
- 2016-06-06 KR KR1020187001229A patent/KR102643849B1/en active IP Right Grant
- 2016-06-06 PT PT167294701T patent/PT3310389T/en unknown
- 2016-06-06 EP EP16729470.1A patent/EP3310389B1/en active Active
- 2016-06-06 DK DK16729470.1T patent/DK3310389T3/en active
- 2016-06-06 JP JP2017563568A patent/JP6997624B2/en active Active
- 2016-06-06 SI SI201630936T patent/SI3310389T1/en unknown
- 2016-06-06 RS RS20200997A patent/RS60672B1/en unknown
- 2016-06-06 CN CN201680035629.7A patent/CN108282998B/en active Active
- 2016-06-06 US US15/173,961 patent/US10251895B2/en active Active
-
2018
- 2018-02-23 US US15/903,785 patent/US10426787B2/en active Active
-
2019
- 2019-04-08 US US16/377,540 patent/US20190231797A1/en not_active Abandoned
-
2020
- 2020-08-04 CY CY20201100719T patent/CY1123354T1/en unknown
- 2020-08-10 HR HRP20201250TT patent/HRP20201250T1/en unknown
-
2021
- 2021-01-21 US US17/154,591 patent/US11679115B2/en active Active
- 2021-07-02 US US17/366,871 patent/US11679116B2/en active Active
-
2022
- 2022-11-23 US US17/993,817 patent/US11648256B2/en active Active
-
2023
- 2023-05-04 US US18/312,162 patent/US20230355640A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017027332A2 (en) | topical compositions comprising a corticosteroid and a retinoid for treating psoriasis. | |
| DK3258942T3 (en) | Cosmetic and topical compositions comprising cannabigerol and cannabidiol | |
| BR112018001190A2 (en) | compositions useful for treating kit and pdfgr-related disorders | |
| ZA201800080B (en) | Topical retinoid compositions | |
| DK3307739T3 (en) | NRF2 regulators | |
| BR112017013320A2 (en) | corrosion inhibiting compositions for acidification treatments | |
| CL2018003443A1 (en) | Treatments for cancer. | |
| ES2973101T3 (en) | Methods to treat proteinopathies | |
| BR112017019352A2 (en) | corticosteroid-compressed topical compositions related applications | |
| CL2019001760A1 (en) | Compositions comprising acetic acid and hypochloric acid and methods for treating a biofilm. | |
| BR112015023273A2 (en) | method for programming ovulation. | |
| BR112018002283A2 (en) | Composition for topical administration to a subject, and, topical formulation | |
| BR112016021875A2 (en) | topical composition | |
| DK3349752T3 (en) | AZA-ADAMANTAN COMPOSITION FOR WOUND HEALING | |
| DK3324938T3 (en) | TOPICAL FORMULATIONS AND TREATMENTS | |
| IL246800A0 (en) | Topical antifungal composition for treating onychomycosis | |
| BR112017016048A2 (en) | anti-inflammatory method and agent | |
| TR201512960A1 (en) | TOPICAL FORMULATIONS | |
| ES1135628Y (en) | MONOBOYA FOR CONTROLLED VERTIDO | |
| CL2018000985A1 (en) | Composition and method to treat substrates. | |
| CL2017002884A1 (en) | Treatments for cancer | |
| MA42111A (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS | |
| DK3349722T3 (en) | TOPICAL HESUTISM TREATMENT | |
| ES1166908Y (en) | Dressing for ointment | |
| CL2016002439A1 (en) | Method for processing arsenic and arsenic containing compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15V | Prolongation of time limit allowed |
Free format text: DE ACORDO COM COMUNICADO PUBLICADO NA RPI 2526 DE 04/06/2019 FICAM DEVOLVIDOS DE 11/06/2019 ATE 14/06/2019 OS PRAZOS VENCIDOS NAS DATAS DIVULGADAS DENTRO DO COMUNICADO. |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/06/2016, OBSERVADAS AS CONDICOES LEGAIS |